COVID-19 Vaccine

Currently anyone 5 and older is eligible to get the vaccine. Certain immunocompromised patients are eligible to get a third dose. Booster shots have been recommended for everyone 12 and older. Booster shots do not need to be the same brand as the primary series. A booster of Moderna (18 and up) or Pfizer (12 and up) is recommended. Boosters of Johnson and Johnson should only be given in certain situations.  

Timing of Vaccine Doses

Primary Series Brand

 

2nd Dose

3rd Dose

Booster

Pfizer

Age 5-11 (pediatric formulation)

21 days after 1st dose

NA

NA

Age 12 and older

21 days after 1st dose

NA

5 months after 2nd Dose

Immunocompromised Age 5-11 (pediatric formulation)

21 days after 1st dose

28 days after 2nd dose

NA

Immunocompromised Age 12 and older

21 days after 1st dose

28 days after 2nd dose

5 months after 3rd Dose

Moderna

Age 18 and older

28 days after 1st dose

NA

5 months after 2nd Dose

Immunocompromised Age 18 and older

28 days after 1st dose

28 days after 2nd dose

5 months after 3rd Dose

Johnson & Johnson

Age 18 and older

NA

NA

2 months after 1st Dose

Information on Healthcare Workforce Mandate

Vaccine Finder

Get Vaccinated Oregon

OHA | COVID-19 Vaccine Website  

OHA | COVID-19 Vaccine FAQs (4/16/21)

AMA | COVID-19 Vaccine FAQs for Providers

Oregon Vaccination Trends

CDC | Possible Side Effects After Getting COVID-19 Vaccine (9/6/21)

Getting the Flu Vaccine at the Same Time as COVID-19 Vaccine

COVID-19 Vaccines During Pregnancy or Breastfeeding

Summary Document for Interim Clinical Considerations
 

Administering Vaccines

Vaccine Provider Enrollment

OHA | Minor Consent Statement (5/25/21)

OHA | Vaccine Information for Providers

Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States (1/6/22)

3rd Doses and Booster Shots

CDC | Booster Shots

CDC | COVID-19 Vaccines for Immunocompromised People

OHA Boosters and Third Doses

Overcoming Vaccine Hesitancy

Vaccinate with Confidence Resources

AMA | COVID-19 Vaccine Script for Patient Inquiries (1/27/21)

AMA | COVID-19 Vaccine FAQs for Patients (3/16/21)

COVID-19 Vaccine Hesitancy in the Health Care Workforce Webinar (1/21/21)

Confronting Health Misinformation


PSA: How Do We Know They Are Safe?

OHA | Vaccine Safety and Effectiveness One Pager

Oregon Health Leadership Counsel | COVID Vaccine Conversations

Safety and Efficacy

Western States Scientific Safety Review Workgroup Recommendations
         Johnson & Johnson (3/6/21)
         Moderna (12/20/20)
         Pfizer (12/13/20)

FDA Emergency Use Authorizations
         Johnson & Johnson (2/27/21)
         Moderna  (12/18/20)
        
FDA Approval of  Pfizer (8/23/21)

How CDC Is Making COVID-19 Vaccine Recommendations

Vaccine Adverse Event Reporting System  

V-Safe Side Effect Reporting Tool

CDC | COVID-19 Vaccine Safety and Effectiveness Reports


Coverage and Reimbursement

CMS | Coverage and Reimbursement of COVID-19 Vaccine Toolkit (5/5/21)

CPT Codes for COVID-19 Vaccines

Vaccine Supplemental Funding FAQs  

Funding for Vaccine Storage and Handling Equipment